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To the Editor 
I have read with great interest a paper published in the advanced online edition in this 
journal.
1
 This paper presented a position statement on renal denervation by the Canadian 
Hypertension Education Program, and stated that “the limited trial data published to date 
have shown clinically significant reduction in BP (blood pressure)”. However, the authors did 
not cite references with different results. For example, in 2012, Brinkmann and colleagues 
showed that renal denervation (N=12) did not decrease office systolic blood pressure (157 
mm Hg versus 157 mm Hg, for baseline and 3–6 months after the procedure).2 Shortly after 
the acceptance of this position paper,  Drs Fadl Elmula and Hart separately reported that renal 
denervation non-significantly decreased office systolic blood pressure by 7–8 mm Hg six 
months after the procedure (P>0.05 for both studies).
3,4
  
Sample sizes of the studies from Drs Brinkmann, Fadl Elmula, and Hart were relative small, 
being 12, 6, and 8, respectively.
2-4
 The non-significant finding of these three studies may be 
due to that the observation time was too short. However, this may be not a major reason, as 
the Symplicity HTN-1 study, the HTN-2 study, and the EnligHTN I study showed that renal 
denervation could significantly decrease office systolic blood pressure even at one month 
after the procedure.  The main reason for the non-significant finding seems to be the variation 
in the blood pressure response to renal denervation. The responder rates (a decrease in office 
systolic blood pressure of ≥ 10 mm Hg) were only 25%, 33%, and 50%, respectively, in the 
reports from Drs Brinkmann,
2
 Fadl Elmula,
3
 and Hart.
4
 These responder rates were lower 
than that in the Symplicity HTN-1 study. In addition, Dr Brinkmann reported that blood 
pressure in 58% of patients remained unchanged or even increased.
2
 These three studies 
highlight that not every patient will respond to renal denervation with a fall in blood pressure 
and in some patients blood pressure may increase. Therefore, an urgent need is highlighted to 
3 
 
investigate predictors of the response of blood pressure to renal denervation, and 
subsequently to avoid possible harm to those non-responders.   
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